Abstract
Natural-product-derived cytotoxics are still widely used in chemotherapy. A review is given of the current level of understanding and emerging trends relevant to the DNA-damaging metabolite families of the bleomycins, 9- and 10-membered enediynes, and mitomycins. A comparison of resistance mechanisms within producing organisms and those predominant among tumor cells reveals potential for continued development of these essential anticancer agents.
Original language | English |
---|---|
Pages (from-to) | 739-758 |
Number of pages | 20 |
Journal | Chemical Reviews |
Volume | 105 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2005 |
ASJC Scopus subject areas
- Chemistry (all)